Related Experiment Videos
Heterotopic bone formation after total hip arthroplasty.
1University of California, Los Angeles School of Medicine.
The Orthopedic Clinics of North America
|April 1, 1992
Summary
Heterotopic bone formation after hip surgery causes pain and limits motion. While its cause is debated, radiotherapy and NSAIDs can prevent it, but surgery is the only cure once it forms.
Area of Science:
- Orthopedic surgery
- Biomedical engineering
- Bone biology
Background:
- Heterotopic ossification (HO) is the formation of bone in non-skeletal tissues, often complicating total hip arthroplasty (THA).
- This complication can lead to significant patient morbidity, including pain and restricted joint mobility, diminishing the success of THA.
- The exact etiology of HO post-THA remains unclear, hindering effective preventative strategies.
Purpose of the Study:
- To review the current understanding of heterotopic bone formation following total hip arthroplasty.
- To evaluate the efficacy of various preventative and treatment modalities for heterotopic ossification.
Main Methods:
- Literature review of studies investigating heterotopic bone formation after total hip arthroplasty.
- Analysis of the effectiveness of diphosphonates, radiotherapy, nonsteroidal anti-inflammatory drugs (NSAIDs), and surgical intervention.
Main Results:
- Diphosphonates have demonstrated ineffectiveness in preventing HO post-THA.
- Radiotherapy and NSAIDs have shown efficacy in preventing the formation of heterotopic bone.
- Surgical excision is currently the sole effective treatment option for established heterotopic bone.
Conclusions:
- Preventative measures like radiotherapy and NSAIDs are crucial for mitigating HO risks after THA.
- Early intervention and surgical management are necessary for patients who develop heterotopic bone, despite preventative efforts.